Jason DuBraski - Firefly Neuroscience, Vice Sales
| AIFF Stock | 2.99 0.10 3.24% |
Executive
Jason DuBraski is Vice Sales of Firefly Neuroscience,
| Address | 150 King St W, Toronto, ON, Canada, M5H 1J9 |
| Phone | 888-237-6412 |
| Web | https://fireflyneuro.com |
Similar Executives
| Found 9 records | EXECUTIVE Age | ||
| Kathy Rudy | Information Services Group | N/A | |
| Asaf CPA | Formula Systems 1985 | 46 | |
| Lois Coatney | Information Services Group | N/A | |
| Paul Gottsegen | Information Services Group | 61 | |
| Guy CPA | Formula Systems 1985 | 56 | |
| Todd Dreger | Information Services Group | N/A | |
| Asaf Berenstin | Formula Systems 1985 | 46 | |
| Frank Zomerfeld | The Hackett Group | N/A | |
| Tammy Koll | Formula Systems 1985 | 48 | |
Firefly Neuroscience, Leadership Team
Elected by the shareholders, the Firefly Neuroscience,'s board of directors comprises two types of representatives: Firefly Neuroscience, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Firefly. The board's role is to monitor Firefly Neuroscience,'s management team and ensure that shareholders' interests are well served. Firefly Neuroscience,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Firefly Neuroscience,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gil Issachar, Chief Officer | ||
| Jason DuBraski, Vice Sales | ||
| David Johnson, Executive Chairman | ||
| Jon Olsen, CEO Director | ||
| Samer MD, Chief Officer | ||
| Stephen Purcell, Chief Officer | ||
| Paul CPA, Chief Officer |
Firefly Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Firefly Neuroscience, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Operating Margin | (125.90) % | ||||
| Current Valuation | 27.19 M | ||||
| Shares Outstanding | 7.34 M | ||||
| Shares Owned By Insiders | 44.82 % | ||||
| Shares Owned By Institutions | 1.02 % | ||||
| Number Of Shares Shorted | 311.06 K | ||||
| Price To Book | 19.64 X | ||||
| Price To Sales | 423.28 X | ||||
| EBITDA | (4.55 M) | ||||
| Net Income | (3.79 M) |
Currently Active Assets on Macroaxis
When determining whether Firefly Neuroscience, is a strong investment it is important to analyze Firefly Neuroscience,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Firefly Neuroscience,'s future performance. For an informed investment choice regarding Firefly Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Firefly Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For more detail on how to invest in Firefly Stock please use our How to Invest in Firefly Neuroscience, guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Firefly Neuroscience,. If investors know Firefly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Firefly Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.98) |
The market value of Firefly Neuroscience, is measured differently than its book value, which is the value of Firefly that is recorded on the company's balance sheet. Investors also form their own opinion of Firefly Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Firefly Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Firefly Neuroscience,'s market value can be influenced by many factors that don't directly affect Firefly Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Firefly Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Firefly Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Firefly Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.